Literature DB >> 1873854

Antigens of melanocytes and melanoma.

S A Lynch1, B N Bouchard, S Vijayasaradhi, H Yuasa, A N Houghton.   

Abstract

Melanoma is a valuable model to study phenotypic traits that are regulated during cell differentiation and malignant transformation. Melanoma cells display extensive phenotypic and antigenic heterogeneity. Studies of this attribute have provided insight into events that take place during normal melanocyte differentiation and give clues to traits that contribute to malignancy. It is possible that the phenotypic and genotypic heterogeneity present among melanoma cells within a single lesion includes a subset of cells with traits that favor tumor progression and metastasis. This review discusses the identification and characterization of antigens expressed by melanoma cells and their potential contribution to melanocyte differentiation and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873854     DOI: 10.1007/bf00049411

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  35 in total

1.  Extracellular matrix-modulated expression of human cell surface glycoproteins A42 and J143. Intrinsic and extrinsic signals determine antigenic phenotype.

Authors:  W J Rettig; V V Murty; M J Mattes; R S Chaganti; L J Old
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

Review 2.  The migration and differentiation of neural crest cells.

Authors:  J A Weston
Journal:  Adv Morphog       Date:  1970

3.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

4.  Purification of an autoantigenic 75-kDa human melanosomal glycoprotein.

Authors:  S Vijayasaradhi; A N Houghton
Journal:  Int J Cancer       Date:  1991-01-21       Impact factor: 7.396

5.  Sialyltransferase levels and ganglioside expression in melanoma and other cultured human cancer cells.

Authors:  I J Thampoe; K Furukawa; E Vellvé; K O Lloyd
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

6.  Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice.

Authors:  S Welt; M J Mattes; R Grando; T M Thomson; R W Leonard; P B Zanzonico; R E Bigler; S Yeh; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.

Authors:  A N Houghton; M C Taormina; H Ikeda; T Watanabe; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.

Authors:  S Vijayasaradhi; B Bouchard; A N Houghton
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

9.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

10.  Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.

Authors:  B Bouchard; B B Fuller; S Vijayasaradhi; A N Houghton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  5 in total

1.  CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.

Authors:  J R Knutson; J Iida; G B Fields; J B McCarthy
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

2.  Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

Authors:  Martina Sanlorenzo; Igor Vujic; Adil Daud; Alain Algazi; Matthew Gubens; Sara Alcántara Luna; Kevin Lin; Pietro Quaglino; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  JAMA Dermatol       Date:  2015-11       Impact factor: 10.282

3.  Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells.

Authors:  Fuchuan Li; Gerdy B Ten Dam; Sengottuvelan Murugan; Shuhei Yamada; Taishi Hashiguchi; Shuji Mizumoto; Kayoko Oguri; Minoru Okayama; Toin H van Kuppevelt; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

4.  Regression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy.

Authors:  Zachary Schwager; Mary E Laird; Jo-Ann Latkowski
Journal:  JAAD Case Rep       Date:  2018-04-30

5.  A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.

Authors:  M E Morrison; S Vijayasaradhi; D Engelstein; A P Albino; A N Houghton
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.